Kira Pharmaceuticals Funding: $46M Raised, Series B (2020)
Kira Pharmaceuticals is based in Cambridge, MD. It has raised $46M in total funding. Latest round: Series B. Backed by Qiming Venture Partners, Quan Capital.
Kira Pharmaceuticals funding overview
Kira Pharmaceuticals is based in Cambridge, MD. Kira Pharmaceuticals has raised $46M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in November 2020. The round record for Kira Pharmaceuticals runs through 2020; nothing later has been disclosed. Investors on record include Qiming Venture Partners, Quan Capital. 2 distinct backers are named across the disclosed rounds.
Kira Pharmaceuticals at a glance
Total raised
$46M
Latest round
Series B
Latest round date
November 2020
Headquarters
Cambridge, MD
Notable investors
Qiming Venture Partners, Quan Capital
Frequently asked about Kira Pharmaceuticals funding
How much has Kira Pharmaceuticals raised?
Kira Pharmaceuticals has raised $46M in total disclosed funding across the rounds on record.
Who has invested in Kira Pharmaceuticals?
Qiming Venture Partners, Quan Capital are named among the investors backing Kira Pharmaceuticals.
What was the latest Kira Pharmaceuticals funding round?
The most recent disclosed round is a Series B, announced in November 2020.
Where is Kira Pharmaceuticals based?
Kira Pharmaceuticals is based in Cambridge, MD.
When did Kira Pharmaceuticals last raise?
The last disclosed Kira Pharmaceuticals round closed in November 2020 at Series B.
Totals shown for Kira Pharmaceuticals aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.
